Platelet-rich plasma in osteoarthritis treatment: review of current evidence

Autor: Lucía Gato-Calvo, Joana Magalhaes, Cristina Ruiz-Romero, Francisco J. Blanco, Elena F. Burguera

Publikováno v: Therapeutic Advances in Chronic Disease, Vol 10 (2019)

Platelet-rich plasma (PRP) is defined as a volume of plasma with a platelet concentration higher than the average in peripheral blood. Many basic, preclinical and even clinical case studies and trials report PRP’s ability to improve musculoskeletal

Externí odkaz: https://doaj.org/article/9f873f8571be4ec89f2d413650022381

Propafenone-Induced Cholestatic Liver Injury: When Diagnosis Does Not Skip a Beat

Autor: Ana Isabel Ferreira, Vítor Macedo Silva, Cátia Arieira, Sofia Xavier, Joana Magalhães, José Cotter

Publikováno v: GE: Portuguese Journal of Gastroenterology, Pp 1-9 (2024)

Introduction: Propafenone is a widely used class Ic antiarrhythmic drug that is mainly metabolised by the liver. Hepatotoxicity associated with propafenone is rare, with only a few clinical cases reported in the literature. Case Presentation: We pres

Externí odkaz: https://doaj.org/article/c22d96464c0741d19a313841aefa4c35

End-of-Life Antibiotherapy: Factors Associated With Prescription

Autor: Elsa Campoa, Júlio Teixeira, Paulo Luz, Joana Magalhaes

Publikováno v: Cureus.

Introduction Most cancer patients spend their last days of life in the hospital, often receiving invasive and non-palliative interventions. These patients are particularly susceptible to infections, which are a major cause of death. The decision to u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6a6b27d2dbca80b9965e4485b8e8455
https://doi.org/10.7759/cureus.31634

Editorial: Bridging citizen science and science communication

Autor: Yaela N. Golumbic, Joana Magalhães, Alice Motion, Joseph Roche

Publikováno v: Frontiers in Environmental Science, Vol 12 (2024)

Externí odkaz: https://doaj.org/article/6b10b82bd5ad46a38a01d8fb5f6c3430

PIAS2-mediated blockade of IFN-β signaling:a basis for sporadic Parkinson disease dementia

Autor: Alexia Montalant, Thomas Gasser, Marco Prinz, Patrick Ejlerskov, Joana Magalhaes, Erling Hu, Shohreh Issazadeh-Navikas, Emilie Tresse, Susana Aznar, Ali Sharifi-Zarchi, Yawei Liu, Carsten Friis Rundsten, Tomasz Brudek, Jesper B. Andersen, Eva Maria Meier Carlsen, Manu Sharma, Jean-François Perrier, Rasmus Rydbirk, Letizia Satriano, Konstantin Khodosevich, Andrea Marin

Publikováno v: Magalhaes, J, Tresse, E, Ejlerskov, P, Hu, E, Liu, Y, Marin, A, Montalant, A, Satriano, L, Rundsten, C F, Carlsen, E M M, Rydbirk, R, Sharifi-Zarchi, A, Andersen, J B, Aznar, S, Brudek, T, Khodosevich, K, Prinz, M, Perrier, J F M, Sharma, M, Gasser, T & Issazadeh-Navikas, S 2021, ' PIAS2-mediated blockade of IFN-β signaling : a basis for sporadic Parkinson disease dementia ', Molecular Psychiatry, vol. 26, pp. 6083–6099 . https://doi.org/10.1038/s41380-021-01207-w
Molecular Psychiatry

Familial Parkinson disease (PD) is associated with rare genetic mutations, but the etiology in most patients with sporadic (s)PD is largely unknown, and the basis for its progression to dementia (sPDD) is poorly characterized. We have identified that

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b29a8e8c7d012f8dd270676bd23231b7
https://curis.ku.dk/portal/da/publications/pias2mediated-blockade-of-ifn-signaling(d386990f-e2ac-44da-a127-61b65c96e865).html